Lifeward Ltd (LFWD)

$7.56 +0.17 (2.30%)
Market Cap 10.44M
Revenue (ttm) 25.66M
Net Income (ttm) -28.94M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -112.78%
Debt to Equity Ratio 0.00
Volume 13,100
Avg Vol 29,228
Day's Range N/A - N/A
Shares Out 1.53M
Stochastic %K 92%
Beta 0.12
Analysts Strong Sell
Price Target $45.02

Company Profile

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gra...

Industry: Medical Devices
Sector: Healthcare
Phone: 972 4 959 0123
Address:
3 Hatnufa Street, Floor 6, Yokneam Illit, Israel
NASDboy
NASDboy Mar. 14 at 4:46 PM
$LFWD gurus on X , threads, and IG pumping this
1 · Reply
emailsl
emailsl Mar. 13 at 9:21 PM
$LFWD
0 · Reply
EvE12
EvE12 Mar. 13 at 12:51 PM
$LFWD https://ir.golifeward.com/news-releases/news-release-details/lifeward-receives-shareholder-approval-close-strategic
1 · Reply
HappyGentelmen
HappyGentelmen Mar. 13 at 12:20 PM
$LFWD Target for the next weeks $50!
0 · Reply
HappyGentelmen
HappyGentelmen Mar. 13 at 12:20 PM
$LFWD News out! Rocket in the make!
0 · Reply
TheTradeXchange
TheTradeXchange Mar. 11 at 12:02 PM
$LFWD - Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 10 at 7:42 PM
$LFWD Share Price: $6.30 Contract Selected: Jul 17, 2026 $7.5 Calls Buy Zone: $0.42 – $0.52 Target Zone: $0.76 – $0.93 Potential Upside: 70% ROI Time to Expiration: 128 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
EvE12
EvE12 Mar. 8 at 11:50 AM
$LFWD The Oramed deal should contribute to the removal of the going-concern warning at LFWD, which should eventually bear fruit and serve as a catalyst.
1 · Reply
Kjskms
Kjskms Mar. 5 at 10:41 AM
$LFWD If the target price is $72, that analyst would sell his house and buy this stock!
0 · Reply
themosad
themosad Mar. 5 at 8:51 AM
$LFWD
0 · Reply
Latest News on LFWD
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company

Mar 13, 2026, 8:00 AM EDT - 4 days ago

Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company

ORMP

Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement

Mar 11, 2026, 8:00 AM EDT - 6 days ago

Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement

Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Mar 10, 2026, 4:15 PM EDT - 7 days ago

Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton

Mar 2, 2026, 8:00 AM EST - 15 days ago

Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton

Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors

Feb 25, 2026, 8:00 AM EST - 20 days ago

Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors

Lifeward Announces Reverse Share Split

Feb 20, 2026, 8:00 AM EST - 25 days ago

Lifeward Announces Reverse Share Split

Lifeward's ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers

Feb 17, 2026, 8:00 AM EST - 4 weeks ago

Lifeward's ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers

Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company

Jan 13, 2026, 8:00 AM EST - 2 months ago

Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company

ORMP

Oramed and Lifeward Announce Strategic Transaction

Jan 13, 2026, 7:58 AM EST - 2 months ago

Oramed and Lifeward Announce Strategic Transaction

ORMP

Lifeward Appoints Bob Marshall as Chairman of the Board

Dec 19, 2025, 4:05 PM EST - 3 months ago

Lifeward Appoints Bob Marshall as Chairman of the Board

Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates

Dec 17, 2025, 8:00 AM EST - 3 months ago

Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates

Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval

Dec 3, 2025, 8:00 AM EST - 3 months ago

Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval

UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton

Nov 17, 2025, 8:00 AM EST - 4 months ago

UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton

Lifeward Ltd. (LFWD) Q3 2025 Earnings Call Transcript

Nov 14, 2025, 11:31 AM EST - 4 months ago

Lifeward Ltd. (LFWD) Q3 2025 Earnings Call Transcript

Lifeward Ltd. Reports Third Quarter 2025 Financial Results

Nov 14, 2025, 8:00 AM EST - 4 months ago

Lifeward Ltd. Reports Third Quarter 2025 Financial Results

Lifeward to Report Third Quarter Financial Results on November 14, 2025

Nov 10, 2025, 7:00 AM EST - 4 months ago

Lifeward to Report Third Quarter Financial Results on November 14, 2025

First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton

Sep 9, 2025, 8:30 AM EDT - 6 months ago

First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton

Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton

Sep 8, 2025, 8:30 AM EDT - 6 months ago

Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton

Lifeward Ltd. (LFWD) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 10:26 PM EDT - 7 months ago

Lifeward Ltd. (LFWD) Q2 2025 Earnings Call Transcript

Lifeward Ltd. Reports Second Quarter 2025 Financial Results

Aug 14, 2025, 8:00 AM EDT - 7 months ago

Lifeward Ltd. Reports Second Quarter 2025 Financial Results

Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership

Aug 13, 2025, 8:00 AM EDT - 7 months ago

Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership

Lifeward to Report Second Quarter Financial Results on August 14, 2025

Aug 7, 2025, 5:30 PM EDT - 7 months ago

Lifeward to Report Second Quarter Financial Results on August 14, 2025

Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region

Aug 4, 2025, 8:30 AM EDT - 8 months ago

Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region

MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion

Jul 7, 2025, 11:00 AM EDT - 9 months ago

MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion

Lifeward Announces Closing of $2.6 Million Public Offering

Jun 26, 2025, 4:15 PM EDT - 9 months ago

Lifeward Announces Closing of $2.6 Million Public Offering

Lifeward Announces Pricing of $2.6 Million Public Offering

Jun 25, 2025, 9:10 AM EDT - 9 months ago

Lifeward Announces Pricing of $2.6 Million Public Offering

Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary

Jun 24, 2025, 4:05 PM EDT - 9 months ago

Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary

Lifeward Names Mark Grant as New CEO

May 19, 2025, 8:30 AM EDT - 10 months ago

Lifeward Names Mark Grant as New CEO

Lifeward to Present at Sidoti Virtual Investor Conference on May 21

May 19, 2025, 6:00 AM EDT - 10 months ago

Lifeward to Present at Sidoti Virtual Investor Conference on May 21

Lifeward Ltd. (LFWD) Q1 2025 Earnings Call Transcript

May 15, 2025, 9:53 AM EDT - 10 months ago

Lifeward Ltd. (LFWD) Q1 2025 Earnings Call Transcript

Lifeward Ltd. Reports First Quarter 2025 Financial Results

May 15, 2025, 8:00 AM EDT - 10 months ago

Lifeward Ltd. Reports First Quarter 2025 Financial Results

Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons

May 8, 2025, 8:30 AM EDT - 11 months ago

Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons

Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025

May 7, 2025, 4:30 PM EDT - 11 months ago

Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025

First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton

Apr 29, 2025, 8:30 AM EDT - 11 months ago

First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton

Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton

Apr 24, 2025, 8:30 AM EDT - 11 months ago

Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton

Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market

Apr 15, 2025, 8:15 AM EDT - 1 year ago

Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market

FDA Issues Clearance for ReWalk 7 Exoskeleton

Mar 13, 2025, 9:15 AM EDT - 1 year ago

FDA Issues Clearance for ReWalk 7 Exoskeleton

Lifeward Ltd. (LFWD) Q4 2024 Earnings Call Transcript

Mar 7, 2025, 11:32 AM EST - 1 year ago

Lifeward Ltd. (LFWD) Q4 2024 Earnings Call Transcript

Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 7, 2025, 8:00 AM EST - 1 year ago

Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results

Lifeward and CorLife Finalize Partnership to Expand Workers' Compensation Access to ReWalk Exoskeleton

Mar 6, 2025, 8:00 AM EST - 1 year ago

Lifeward and CorLife Finalize Partnership to Expand Workers' Compensation Access to ReWalk Exoskeleton

Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use

Mar 5, 2025, 8:00 AM EST - 1 year ago

Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use

Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025

Feb 28, 2025, 8:00 AM EST - 1 year ago

Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025

Lifeward Announces CEO Transition

Feb 19, 2025, 9:10 AM EST - 1 year ago

Lifeward Announces CEO Transition

Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities

Jan 13, 2025, 8:30 AM EST - 1 year ago

Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities

Lifeward Cancels Its Extraordinary General Meeting of Shareholders

Jan 13, 2025, 7:45 AM EST - 1 year ago

Lifeward Cancels Its Extraordinary General Meeting of Shareholders

Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jan 8, 2025, 4:15 PM EST - 1 year ago

Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jan 7, 2025, 8:05 AM EST - 1 year ago

Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders

Dec 27, 2024, 5:49 PM EST - 1 year ago

Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders

Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons

Nov 19, 2024, 8:30 AM EST - 1 year ago

Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons

Lifeward Ltd. (LFWD) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 11:30 AM EST - 1 year ago

Lifeward Ltd. (LFWD) Q3 2024 Earnings Call Transcript

NASDboy
NASDboy Mar. 14 at 4:46 PM
$LFWD gurus on X , threads, and IG pumping this
1 · Reply
emailsl
emailsl Mar. 13 at 9:21 PM
$LFWD
0 · Reply
EvE12
EvE12 Mar. 13 at 12:51 PM
$LFWD https://ir.golifeward.com/news-releases/news-release-details/lifeward-receives-shareholder-approval-close-strategic
1 · Reply
HappyGentelmen
HappyGentelmen Mar. 13 at 12:20 PM
$LFWD Target for the next weeks $50!
0 · Reply
HappyGentelmen
HappyGentelmen Mar. 13 at 12:20 PM
$LFWD News out! Rocket in the make!
0 · Reply
TheTradeXchange
TheTradeXchange Mar. 11 at 12:02 PM
$LFWD - Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 10 at 7:42 PM
$LFWD Share Price: $6.30 Contract Selected: Jul 17, 2026 $7.5 Calls Buy Zone: $0.42 – $0.52 Target Zone: $0.76 – $0.93 Potential Upside: 70% ROI Time to Expiration: 128 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
EvE12
EvE12 Mar. 8 at 11:50 AM
$LFWD The Oramed deal should contribute to the removal of the going-concern warning at LFWD, which should eventually bear fruit and serve as a catalyst.
1 · Reply
Kjskms
Kjskms Mar. 5 at 10:41 AM
$LFWD If the target price is $72, that analyst would sell his house and buy this stock!
0 · Reply
themosad
themosad Mar. 5 at 8:51 AM
$LFWD
0 · Reply
HappyGentelmen
HappyGentelmen Feb. 26 at 11:15 AM
$LFWD next leg up $10.
2 · Reply
InfernoWyrm
InfernoWyrm Feb. 25 at 7:07 PM
$NVTS $ASPS $SGML $LFWD ^^
0 · Reply
blocktrade
blocktrade Feb. 25 at 6:48 PM
$LFWD next move will be to do a a bunch of secondaries and dilute the shares again until the next reverse stock split. Wash, rinse , repeat.
0 · Reply
mezquita
mezquita Feb. 25 at 6:39 PM
$LFWD When will these useless people give away the 10 million shares to Oramed?
1 · Reply
topstockalerts
topstockalerts Feb. 25 at 6:07 PM
$LFWD Steady stair step move higher with shallow pullbacks. Buyers showing up consistently. Clearing recent highs keeps trend intact.
0 · Reply
cdub081012
cdub081012 Feb. 25 at 2:07 PM
$LFWD $4.X target price before this thing takes off???
0 · Reply
EvE12
EvE12 Feb. 25 at 1:06 PM
$LFWD https://ir.golifeward.com/news-releases/news-release-details/lifeward-acquire-powered-upper-body-exoskeleton-ai-capabilities
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 24 at 9:15 PM
$LFWD Current Stock Price: $5.05 Contracts to trade: $1.0 LFWD Mar 20 2026 Call Entry: $0.05 Exit: $0.09 ROI: 96% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
TwongStocks
TwongStocks Feb. 24 at 9:03 PM
Today's reverse split results. $LFWD 1 for 12 Previous close $0.3829, $4.5948 split-adjusted Intraday high $5.23 Today's close $5.01 🟢Up 9.04% $RPGL 1 for 20 Previous close $0.2744, $5.488 split-adjusted Intraday high $8.44 Today's close $6.42 🟢Up 16.98% $TRNR 1 for 10 Previous close $0.2191, $2.191 split-adjusted Intraday high $2.50 Today's close $2.30 🟢Up 4.97%
0 · Reply
TwongStocks
TwongStocks Feb. 24 at 12:57 PM
$LFWD $RPGL $TRNR All three with reverse splits today. Trading is scheduled to resume at 9am ET with the RS in effect. RS details in the quoted post.
0 · Reply
FreeBeerTomorrow
FreeBeerTomorrow Feb. 24 at 8:25 AM
$LFWD * LFWD - the company executed a 1-for-12 reverse split that became effective today, February 24, 2026. Estimated Post-Split Float: ~1.5 million shares .
0 · Reply
PaulLaurent
PaulLaurent Feb. 24 at 6:51 AM
🔁 Reverse Splits — February 24, 2026 $TRNR – 1 for 10 | Former float: 5.25M | New float est: 525K $RPGL – 1 for 20 | Former float: 6.35M | New float est: 318K $LFWD – 1 for 12 | Former float: 17.97M | New float est: 1.50M $DULL – 1 for 50 | Former float: 13.50M | New float est: 270K $BNKD – 1 for 5 | Former float: 160K | New float est: 32K
0 · Reply